Salem Alshemmari

1.2k total citations
48 papers, 575 citations indexed

About

Salem Alshemmari is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Salem Alshemmari has authored 48 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 18 papers in Pathology and Forensic Medicine and 13 papers in Oncology. Recurrent topics in Salem Alshemmari's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Viral-associated cancers and disorders (6 papers). Salem Alshemmari is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Viral-associated cancers and disorders (6 papers). Salem Alshemmari collaborates with scholars based in Kuwait, United States and Egypt. Salem Alshemmari's co-authors include Reem Ameen, Hejab Al‐Ajmi, Qasem A. Alsaleh, Marie‐France Demierre, Arti Nanda, Iqbal Siddique, Samy A. Alsirafy, Rafiqul I. Chowdhury, Javid Gaziev and Kamal M. Matar and has published in prestigious journals such as Blood, Scientific Reports and Journal of Histochemistry & Cytochemistry.

In The Last Decade

Salem Alshemmari

43 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salem Alshemmari Kuwait 14 216 181 177 137 121 48 575
Naomi B. Klarenbeek Netherlands 16 247 1.1× 139 0.8× 55 0.3× 24 0.2× 107 0.9× 36 885
Mathias Schneeweiss‐Gleixner Austria 10 73 0.3× 70 0.4× 108 0.6× 22 0.2× 29 0.2× 29 455
Olav Bjørneboe Norway 11 153 0.7× 105 0.6× 43 0.2× 47 0.3× 88 0.7× 19 674
Alex Hendrick United Kingdom 11 121 0.6× 71 0.4× 126 0.7× 104 0.8× 21 0.2× 17 467
Merete Pedersen Denmark 8 83 0.4× 57 0.3× 104 0.6× 24 0.2× 92 0.8× 14 720
Cyrus C. Hsia Canada 11 258 1.2× 118 0.7× 25 0.1× 50 0.4× 62 0.5× 83 541
Elif Suyanı Türkiye 11 165 0.8× 47 0.3× 70 0.4× 25 0.2× 43 0.4× 41 381
David L. Hyslop United States 7 89 0.4× 63 0.3× 61 0.3× 13 0.1× 48 0.4× 14 394
Steven Jungerwirth United States 7 134 0.6× 72 0.4× 47 0.3× 22 0.2× 27 0.2× 8 483
Sergio Mecarocci Italy 11 116 0.5× 38 0.2× 87 0.5× 21 0.2× 40 0.3× 22 432

Countries citing papers authored by Salem Alshemmari

Since Specialization
Citations

This map shows the geographic impact of Salem Alshemmari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salem Alshemmari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salem Alshemmari more than expected).

Fields of papers citing papers by Salem Alshemmari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salem Alshemmari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salem Alshemmari. The network helps show where Salem Alshemmari may publish in the future.

Co-authorship network of co-authors of Salem Alshemmari

This figure shows the co-authorship network connecting the top 25 collaborators of Salem Alshemmari. A scholar is included among the top collaborators of Salem Alshemmari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salem Alshemmari. Salem Alshemmari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Alhuraiji, Ahmad, et al.. (2023). Adolescents and Young Adults with Multiple Myeloma, Kuwait Experience. Blood. 142(Supplement 1). 6641–6641. 1 indexed citations
3.
Alshemmari, Salem, et al.. (2023). Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. Acta Haematologica. 147(3). 260–279. 1 indexed citations
4.
Alshemmari, Salem, et al.. (2022). Epidemiology of de novo Acute Myeloid Leukemia in Kuwait per the 2016 WHO Classification. Medical Principles and Practice. 31(3). 284–292. 3 indexed citations
5.
Hasan, Amal, et al.. (2022). Fatal COVID-19 is Associated with Reduced HLA-DR, CD123 or CD11c Expression on Circulating Dendritic Cells. Journal of Inflammation Research. Volume 15. 5665–5675. 1 indexed citations
6.
Pinto, Karen, et al.. (2021). Primary Mediastinal Large B-cell Lymphoma. Hematology/Oncology and Stem Cell Therapy. 15(4). 196–200. 1 indexed citations
7.
Alshemmari, Salem, et al.. (2021). Chronic lymphocytic leukemia in a young population. Leukemia Research. 110. 106668–106668. 3 indexed citations
8.
Pinto, Karen, et al.. (2020). Promising effect of PDL1 inhibitors in the front-line management of primary aggressive central nervous system lymphoma: A case report. Hematology/Oncology and Stem Cell Therapy. 6 indexed citations
9.
Ivanova, Milena, Lisa E. Creary, Michela Mazzocco, et al.. (2019). 17th IHIW component “Immunogenetics of Ageing” – New NGS data. Human Immunology. 80(9). 703–713. 9 indexed citations
10.
Usmani, Sharjeel, et al.. (2015). The role of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with mycosis fungoides. Indian Journal of Nuclear Medicine. 30(3). 199–199. 7 indexed citations
11.
Alshemmari, Salem, et al.. (2013). Genetic and Immunohistochemical Characterization of Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma. Acta Haematologica. 131(1). 1–10. 9 indexed citations
12.
Alshemmari, Salem, et al.. (2012). The Palliative Prognostic Index for the Prediction of Survival and In-Hospital Mortality of Patients with Advanced Cancer in Kuwait. Journal of Palliative Medicine. 15(2). 200–204. 18 indexed citations
13.
Alshemmari, Salem, et al.. (2012). Representation of Expatriates Among Cancer Patients in Kuwait and the Need for Culturally-Competent Care. Journal of Psychosocial Oncology. 30(3). 380–385. 3 indexed citations
14.
Al–Herz, Waleed, et al.. (2010). Performance status and deaths among children registered in Kuwait National Primary Immunodeficiency Disorders Registry. Asian Pacific Journal of Allergy and Immunology. 28(2-3). 141–6. 9 indexed citations
15.
Boyden, Steven E., Mustafa A. Salih, Anna R. Duncan, et al.. (2010). Efficient identification of novel mutations in patients with limb girdle muscular dystrophy. Neurogenetics. 11(4). 449–455. 14 indexed citations
16.
Nanda, Arti, et al.. (2010). Mycosis Fungoides in Arab Children and Adolescents: A Report of 36 Patients from Kuwait. Pediatric Dermatology. 27(6). 607–613. 48 indexed citations
17.
Alsaleh, Qasem A., et al.. (2010). Clinicoepidemiological features of mycosis fungoides in Kuwait, 1991–2006. International Journal of Dermatology. 49(12). 1393–1398. 35 indexed citations
18.
19.
Ameen, Reem, et al.. (2003). RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients. Transfusion. 43(11). 1604–1610. 135 indexed citations
20.
Alshemmari, Salem, et al.. (2002). Radiotherapy for Early Stage of Hodgkin’s Disease at Kuwait Cancer Control Center, Kuwait. Medical Principles and Practice. 11(3). 147–149. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naomi B. Klarenbeek Breakdown of academic impact, for papers by Mathias Schneeweiss‐Gleixner Breakdown of academic impact, for papers by Olav Bjørneboe Breakdown of academic impact, for papers by Alex Hendrick Breakdown of academic impact, for papers by Merete Pedersen Breakdown of academic impact, for papers by Cyrus C. Hsia Breakdown of academic impact, for papers by Elif Suyanı Breakdown of academic impact, for papers by David L. Hyslop Breakdown of academic impact, for papers by Steven Jungerwirth Breakdown of academic impact, for papers by Sergio Mecarocci
Rankless by CCL
2026